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doi:10.1016/j.jmu.2011.10.005Transthoracic Doppler echocardiography (TDE) is a noninvasive tool for measuring coronary
flow reserve in the epicardial coronary arteries. In the absence of stenosis in the epicardial
coronary artery, TDE can detect impaired microvascular vasodilatation associated with
diseases, including reperfused myocardial infarct, systemic arterial hypertension, diabetes
mellitus, coronary vasospasm, microvascular angina, and hypertrophic cardiomyopathy by
demonstrating a decrease in the coronary flow reserve. Because it is noninvasive, TDE allows
for serial coronary flow reserve evaluations to explore the effect of various therapies. This
noninvasive imaging technique expands the field of diagnostic echocardiography and brings
new insight into the pathophysiology of ischemic heart disease. This review outlines rationale
of TDE to evaluate coronary flow reserve in the left anterior descending coronary artery and
discusses its clinical applications.
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Coronary flow reserve (CFR) is defined as the ratio of
hyperemic (stimulated) to baseline (resting) coronary blood
flow for a given perfusion pressure [1]. CFR measurement is
used both to assess epicardial coronary stenoses and to
examine the integrity of microvascular circulation. In the
absence of coronary artery stenoses, the CFR may be
decreased when coronary microvascular circulation isof Ultrasound in Medicine. Open access under CC BY-NC-ND license.
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coronary vasospasm, cardiac syndrome X, and hypertrophic
cardiomyopathy [2].Functional anatomy of the coronary arterial
system
The coronary arterial system is composed of three
compartments with different functions, although the
borders of each compartment cannot be clearly defined
anatomically [3]. The first compartment of the coronary
arterial system is known as the proximal compartment and
is comprised of conductive arteries. It is represented by the
large epicardial coronary arteries, which have a capaci-
tance function and offer little resistance to coronary blood
flow. The diameter of the epicardial coronary arteries
ranges from approximately 500 mm to 2e5 mm. The second
compartment of the coronary arterial system is known as
the intermediate compartment. It is comprised of pre-
arterioles that are characterized by a measurable pressure
drop along their length. These vessels are not under direct
vasomotor control by diffusible myocardial metabolites
because of their extramyocardial position and wall thick-
ness. Their diameter ranges from approximately
100e500 mm, and their specific function is to maintain
pressure at the origin of the arterioles within a narrow
range when coronary perfusion pressure or flow changes.
The third compartment of the coronary arterial system is
known as the distal compartment. It is comprised of
intramural arterioles that are characterized by a consider-
able drop in pressure along their path. The intramural
arterioles have diameters of less than 100 mm, and their
function is the matching of myocardial blood supply and
oxygen consumption.
When blood flow changes, epicardial coronary arteries
and proximal arterioles have an intrinsic tendency to
maintain a given level of shear stress by endothelial-
dependent dilatation [4]. When aortic pressure increases,
distal prearterioles undergo myogenic constriction to
maintain a constant pressure at the origin of the arterioles.
Arterioles have a fundamental role in the metabolic regu-
lation of coronary blood flow [5]. They have a high resting
tone and dilate in response to the release of metabolites by
the myocardium as a result of an increase in oxygen
consumption. Arteriolar dilatation decreases both resis-
tance in the overall network and pressure in the distal
prearterioles, which in turn induce the dilatation of myo-
genically sensitive vessels. Furthermore, the dilatation of
distal prearterioles and arterioles results in an increase in
shear stress, which triggers flow-dependent dilatation in
larger prearterioles and conductance arteries. Coronary
microvascular dysfunction is defined as disordered function
of small coronary resistance vessels (<100e200 mm) [6].Assessment of the coronary microcirculation
Presently, there is no technique to visualize coronary
microcirculation in vivo in humans. Several measurements
that rely on the quantification of blood flow through the
coronary circulation are commonly used to assess thefunction of coronary microvasculature. Coronary blood flow
is a measurement of the amount of flow through a given
coronary vessel per unit of time and is usually expressed in
milliters per minute [7]. Techniques for measuring coronary
blood flow include intracoronary thermodilution, which
uses a thermal dilution curve to measure blood flow, and an
intracoronary Doppler wire, which measures blood flow
ultrasonographically according to the Doppler principle.
Another invasive technique for assessing coronary blood
flow is the Thrombolysis in Myocardial Infarction (TIMI)
frame count. It does not quantify the flow, but it is useful
for comparative purposes [8]. Recently, transthoracic
Doppler echocardiography (TDE) has been used as a nonin-
vasive technique to measure coronary blood flow [6,9].
CFR is themagnitude of the increase in coronary flow that
is achieved from basal coronary perfusion to maximal coro-
nary vasodilation. Since flow resistance is primarily deter-
mined by themicrovasculature, CFR is ameasurement of the
ability of the microvasculature to respond to a stimulus and,
therefore, presumably of the function of the small vessels.
CFR is determined by measuring the coronary or myocardial
blood flow both at rest (basal flow) and with maximal
hyperemia, and it is achieved with an intracoronary or
intravenous infusion of adenosine or an intravenous infusion
of dipyridamole. CFR is then expressed as the ratio of blood
flow during hyperemia to blood flow at rest. Echocardio-
graphic CFR is defined as the ratio of hyperemic to basal peak
diastolic coronary flow. In patients with coronary artery
disease (CAD), the extent of the reduction in CFR is directly
related to the severity of stenosis, whereas in persons with
angiographically normal arteries it is a marker of microvas-
cular dysfunction [7]. A CFR of less than 2.0 is often
considered abnormal (Fig. 1) [10].
Coronary microcirculatory dysfunction affects the left
ventricle globally [11] and regionally [12]; therefore, CFR
assessment of left anterior descending (LAD) artery, which
would be inadequate for CAD detection, is an excellent
option for evaluating the global coronary microcirculation
[10]. The application of the latest ultrasound technology of
the second harmonic has gained a great step in ultrasound
coronary evaluation. By applying anatomical knowledge
and the newest technical applications, it is now possible to
make a complete a coronary evaluation of the LAD artery in
clinical practice.Ultrasound coronary anatomy reference points
The LAD coronary anatomy is the first artery investigated
with ultrasound when using a transesophageal or trans-
thoracic approach. The first anatomical structure is the
proximal LAD artery. The left atrial appendage and
pulmonary artery represent the key reference points in
detecting the proximal LAD coronary tract. The second
anatomical structure is the intermediate LAD artery. The
septal perforans branches represent the key references
obtainable by regulating the probe slightly lower and
maintaining the focus on the anterior interventricular
sulcus. The third anatomical structure is the distal LAD
tract, which can be highlighted by investigating the lower
part of the interventricular anterior sulcus near the apex
under Color Doppler guidance and by adopting growing
Fig. 1 A synthetic view of different anatomic (first row) and coronary flow reserve (CFR) response (last row). In the normal
condition (left), there is a normal CFR response [ratio of hyperemic (light red, A0) to basal (dark red, A) peak diastolic coronary flow
velocity >3]. An abnormal CFR response can be noted in the presence of microvascular disease or mild-to-moderate epicardial
coronary artery stenosis (second column from left). With more advanced epicardial coronary artery stenosis (third column from
left), more reduction of CFR is found.
TDE in the Anterior Descending Coronary Artery 117delivery frequencies [5e7 Mhz in the second harmonic
(Fig. 2A)]. The distal LAD tract is more suitable to investi-
gate coronary microvascular function because it is between
the large epicardial LAD arteries and microvasculature. By
subsequently applying Pulse Doppler inside the coronary
vessel, we may obtain the coronary spectrum (Fig. 3A) and
therefore quantify it (Fig. 3B). It is now possible toFig. 2 Using a modified parasternal long-axis. (A) Transthoracic co
distal portion of the (B) left anterior descending coronary artery. Ainvestigate the LAD artery by TDE in 95%e98% of patients
[13,14].
The appropriate TDE settings
It is important to apply the current parameters to high-
light the distal LAD artery: (1) the probe deliverylor Doppler recording shows coronary blood flow (arrows) in the
oZ aorta; LAZ left atrium; LVZ left ventricle.
Fig. 3 Transthoracic Doppler echocardiography showing (A) coronary blood flow; and (B) quantitative analysis.
118 M.-J. Hung, W.-J. Cherngfrequencies are 5e7 Mhz as the second harmonic, (2) the
color Doppler flow velocity range is 12e24 centimeters/
second, (3) the wall filter is high, and (4) the pulse
Doppler filter is low. The color gain is adjusted to provide
optimal images.
Position of the TDE probe
The acoustic window is around the midclavicular line in the
fourth and fifth intercostal spaces in the left lateral
decubitus position. The ultrasound beam is transmitted
toward the heart to visualize coronary blood flow in the
distal portion of the LAD artery by color Doppler flow
mapping. First, the left ventricle is imaged in the long-axis
cross-section (Fig. 2A), then the ultrasound beam is
inclined laterally. Next, the coronary blood flow in the
distal LAD is searched for under the color Doppler flow
mapping guidance (Fig. 2B). After positioning a sample
volume (2.0-, 2.5-, or 3.0-mm wide) on the color signal in
the distal LAD artery, Doppler spectral tracings of flow
velocity are recorded by fast Fourier transformation anal-
ysis. Angle correction is needed in each examination
because of the incident Doppler angle. The spectral
Doppler tracing of the LAD artery flow shows a character-
istic biphasic flow pattern with a larger diastolic compo-
nent and a smaller systolic one (Figs. 1 and 3A). To obtain
a correct CFR, the sample volume should be accurately
positioned and maintained throughout the injection of the
vasodilator agent. Although dipyridamole (0.84 mg/kg/
minutes over 6 minutes continuously) and adenosine
(140 mg/kg/minutes for 2e6 minutes with infusion time,
depending on operator skills) can be used as hyperemic
stressors, adenosine is preferable because it reaches the
hyperemic peak induction within 1 minute, acts mainly at
the level of the microcirculation, and it does not signifi-
cantly alter the diameter of the coronary artery [15]. In
addition, the shorter half-life (10 seconds) and rapid onset
of action make the CFR measurements more rapid and it
produces less adverse reactions [16]. Although adenosine is
safe, it is contraindicated in people with bronchial asthmaand may be poorly tolerated in others due to its adverse
events.
Clinical applications of TDE CFR
Angiographically obstructive coronary artery
disease
The cutoff value of <2 of CFR is precise for detecting
significant (> 75%) LAD stenosis with a sensitivity of 86% and
a specificity of 70% [14]. The same CFR criteria can also be
applied to right coronary artery and left circumflex artery
[14]. The CFR <1, which suggests coronary steal, may be
a predictor of critical stenosis (>90%) [17]. Resting coronary
flow pattern can be decreased in the presence of severe
coronary artery stenosis. Without pharmacological stress,
the cutoff point of 1.6 for peak diastolic to systolic flow
velocity ratio has high sensitivities and specificities for
predicting coronary artery stenosis (> 85%) [18] and
reversible perfusion defects in thallium 201 single photon-
emission computed tomography [19].
For angioplasty monitoring, a CFR <2 during follow-up
after angioplasty, the restenosis in the LAD is detected with
high-sensitivity and specificity [20,21]. The cutoff value of
2 for CFR at a time point is useful but it probably less
sensitive than its evolution over time to detect restenosis
after angioplasty. Therefore, a reference value of CFR
should be established in a patient to assess the follow-up
value in this setting [22]. For postinfarction CFR assess-
ment, the decreased CFR <1.5 predicts an increase in left
ventricular volume (i.e., remodeling) after reperfused
myocardial infarction [23]. Another study [24] found that
preconditioning due to preinfarction angina has a protec-
tive role on microvascular function as demonstrated by CFR
preservation (>2.5) after myocardial infarction. From
a prognostic point of view, a reduced CFR (1.92) is the
best predictor of future events in patients with known or
suspected CAD, and the negative stress echocardiography
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are not affected by concomitant antiischemic therapy at
the time of testing [26].
Without angiographically obstructive coronary artery
disease
Several diseases such as hypertrophy (due to aortic
stenosis, hypertrophic cardiomyopathy, and hypertension),
diabetes mellitus, smoking, coronary vasospasm, and
menopause can cause structural and/or functional abnor-
malities of the microcirculation [2]. Because invasive
Doppler measurement of CFR is not routinely performed in
patients with chest pain and angiographically normal
coronary arteries, the extent of such microvascular disease
is likely underestimated. Accordingly, recent studies
[27,28] have demonstrated that 22% of patients with chest
pain and normal or near normal coronary angiography have
CFR <2.0. Noninvasive assessment of CFR using TDE has
been performed in patients with hypertrophic cardiomy-
opathy [29], aortic stenosis [30], diabetes mellitus [10],
and in those who smoke [31]. Additionally, the effect of
physiological hypertrophy on CFR is measurable by TDE
[32], which could prove useful in differentiating an
athlete’s hypertrophic heart, in which CFR is in the normal
to supranormal range, and from a patient with hypertro-
phic cardiomyopathy, in which CFR is markedly attenu-
ated. Importantly, noninvasive TDE allows serial CFR
evaluation to explore the effects of various therapies
[17,33e35].
Diffuse coronary vasospasm was associated with signifi-
cantly reduced vasodilatory reaction compared with focal
vasospasm despite the finding that vasodilatory response of
the epicardial coronary artery to isosorbide dinitrate was
maintained in patients with focal and diffuse vasospasm
compared with controls. Studies using different techniques
of the thermal dilution method suggested that microvas-
cular impairment could explain the restricted CFR in
patients with diffuse vasoconstriction [36,37]. Further-
more, CFR was maintained in patients with focal vaso-
spasm, and normal microvascular function was suspected in
these cases. Nitrates can provide relief in the treatment of
focal vasoconstriction but are less effective in patients with
diffuse vasospasm, who may require vasorelaxants of
microvessels, such as potassium channels openers [38,39].
Limited atherosclerotic lesions have been demonstrated at
the site of focal vasospasm by using intravascular ultra-
sound, and it has been suggested as a cause of focal vaso-
spasm [40,41]. CFR might be maintained in patients with
focal vasospasm if the pathologic mechanism is related to
localized endothelial dysfunction due to the existence of
such limited atherosclerotic lesions as there would be no
microvascular dysfunction. Thus, the mechanism of focal
vasospasm might be related to localized endothelial
dysfunction of the epicardial coronary artery, which causes
a hypersensitive vasoconstrictive reaction to ergonovine
malate in the coronary artery [42].Limitations
The angle between the Doppler beam and the artery can be
large (>30) ad cause an underestimation of the true flowvelocity. However, for the purposes of CFR measurement,
the absolute velocity value is not needed because CFR is
a quotient of two diastolic velocities. For a poor ultrasound
window, under some circumstances such as obesity and
chronic lung conditions, the use of an intravenous contrast
agent can improve the feasibility and quality of CFR
measurements [43,44].Pitfalls
Mapping different coronary arteries from the LAD artery
such as diagonal or the ramus branch cannot be excluded
completely. Additionally, CFR must be measured distally to
stenosis because CFR measurement at the stenosis site is
underestimated due to an increased baseline flow velocity.Conclusion
TDE is a convenient tool for measuring CFR in epicardial
coronary arteries (predominantly in the LAD artery). An
appropriate echo machine setting is important to study
CFR. Resting CFR or pharmacologically induced CFR can
effectively predict significant coronary artery stenosis. In
the absence of stenosis in the epicardial LAD coronary
artery, decreased CFR enables the detection of impaired
microvascular vasodilatation in women subjects and in
patients with arterial hypertension, diabetes mellitus, and
coronary vasospasm [45,46]. In addition, noninvasive TDE
allows serial CFR assessments to explore the effect of
various therapies.References
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